Azithromycin Sustained-Release (2 g)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Azithromycin Sustained-Release (2 g), covering 2011-06-08 to 2011-06-08. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery [Phase 2]